Related Experiment Video
Updated: Dec 15, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.4K
Recurrent Talaromyces marneffei Infection Presenting with Intestinal Obstruction in a Patient with Systemic Lupus
Yu-Kun Zhao1, Jing-Ye Liu2, Juan-Hua Liu1
1Department of Dermatology, The Eastern Division of The First Affiliated Hospital, Sun Yat-sen University, 183 Huangpu Rd. E., Guangzhou, 510700, People's Republic of China.
Mycopathologia
|July 11, 2020
Summary
Talaromyces marneffei can infect non-HIV individuals, causing intestinal obstruction in a patient with systemic lupus erythematosus (SLE). Recurrent infection was treated successfully with itraconazole, but the patient later died from unknown causes.
Area of Science:
- Mycology
- Infectious Diseases
- Gastroenterology
Background:
- Talaromyces marneffei is an opportunistic fungal pathogen primarily affecting individuals with HIV/AIDS.
- While rare, Talaromyces marneffei can cause infections in immunocompetent individuals.
- Systemic lupus erythematosus (SLE) is an autoimmune disease that can increase susceptibility to infections.
Observation:
- A 51-year-old woman with a 14-year history of SLE and disseminated talaromycosis experienced partial intestinal obstruction.
- Talaromyces marneffei infection was confirmed as the cause of the obstruction.
- Genetic analysis suggested the current infection was a recurrence of a previous Talaromyces marneffei episode.
Findings:
- Surgical excision of the affected intestine followed by oral itraconazole (400 mg daily for 3 months) resulted in an excellent clinical response.
- Despite initial treatment success, the patient died from an unknown cause over a year later.
- Literature review on Talaromyces marneffei infections associated with SLE and isolated intestinal talaromycosis was conducted.
Implications:
- This case highlights the potential for Talaromyces marneffei to cause severe gastrointestinal complications, including intestinal obstruction, in patients with SLE.
- Recurrent Talaromyces marneffei infections can occur even after successful treatment.
- Further research is needed to understand the long-term outcomes and management strategies for talaromycosis in non-HIV-infected individuals, particularly those with autoimmune diseases.
Related Concept Videos
Pulmonary Tuberculosis III
781
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
781
Fungal Phylum Microsporidia
308
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
308
Barrett Esophagus-II: Clinical Manifestations and Management
593
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
593
